These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

42 related items for PubMed ID: 8962192

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The antiproliferative effect of malononitrilamides (MNAs) on vascular smooth muscle cells is antagonized by exogenous uridine.
    Czech J, Kurrle R, Schorlemmer HU.
    Inflamm Res; 1999 Dec; 48 Suppl 2():S128-9. PubMed ID: 10667848
    [No Abstract] [Full Text] [Related]

  • 24. Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?
    Zielinski T, Zeitter D, Müller S, Bartlett RR.
    Inflamm Res; 1995 Aug; 44 Suppl 2():S207-8. PubMed ID: 8548402
    [No Abstract] [Full Text] [Related]

  • 25. Effect of cyclosporin on vascular smooth muscle cells.
    Reidy MA.
    Lab Invest; 1991 Jul; 65(1):1-2. PubMed ID: 2072660
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 2H-1,3-oxazine-2,6(3H)-dione, a new pyrimidine antimetabolite.
    Skoda J, Flegelová Z, Farkas J.
    Biochem Biophys Res Commun; 1973 Jan 04; 50(1):80-3. PubMed ID: 4567086
    [No Abstract] [Full Text] [Related]

  • 30. Reduced vasorin enhances angiotensin II signaling within the aging arterial wall.
    Pintus G, Giordo R, Wang Y, Zhu W, Kim SH, Zhang L, Ni L, Zhang J, Telljohann R, McGraw KR, Monticone RE, Ferris C, Liu L, Wang M, Lakatta EG.
    Oncotarget; 2018 Jun 05; 9(43):27117-27132. PubMed ID: 29930755
    [Abstract] [Full Text] [Related]

  • 31. The antiproliferative effect of leflunomide on vascular smooth muscle cells in vitro is mediated by selective inhibition of pyrimidine biosynthesis.
    Nair RV, Cao W, Morris RE.
    Transplant Proc; 1996 Dec 05; 28(6):3081. PubMed ID: 8962192
    [No Abstract] [Full Text] [Related]

  • 32. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW, Huang HC.
    Br J Pharmacol; 1998 Jul 05; 124(6):1029-40. PubMed ID: 9720770
    [Abstract] [Full Text] [Related]

  • 33. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A, Lee I, Grabarek J, Darzynkiewicz Z, Ferreri NR.
    Circulation; 2003 Aug 26; 108(8):1015-21. PubMed ID: 12912810
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate.
    Sharma SK, Zahradka P, Chapman D, Kumamoto H, Takeda N, Dhalla NS.
    J Pharmacol Exp Ther; 1999 Sep 26; 290(3):1475-81. PubMed ID: 10454527
    [Abstract] [Full Text] [Related]

  • 35. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
    del Rio M, Sunkel C, Larcher F, Ortega MP.
    Br J Pharmacol; 1997 Apr 26; 120(7):1360-6. PubMed ID: 9105713
    [Abstract] [Full Text] [Related]

  • 36. The antiproliferative effect of leflunomide on vascular smooth muscle cells in vitro is mediated by selective inhibition of pyrimidine biosynthesis.
    Nair RV, Cao W, Morris RE.
    Transplant Proc; 1996 Dec 26; 28(6):3081. PubMed ID: 8962192
    [No Abstract] [Full Text] [Related]

  • 37. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW, Huang HC.
    Br J Pharmacol; 1998 Jul 26; 124(6):1029-40. PubMed ID: 9720770
    [Abstract] [Full Text] [Related]

  • 38. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A, Lee I, Grabarek J, Darzynkiewicz Z, Ferreri NR.
    Circulation; 2003 Aug 26; 108(8):1015-21. PubMed ID: 12912810
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate.
    Sharma SK, Zahradka P, Chapman D, Kumamoto H, Takeda N, Dhalla NS.
    J Pharmacol Exp Ther; 1999 Sep 26; 290(3):1475-81. PubMed ID: 10454527
    [Abstract] [Full Text] [Related]

  • 40. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
    del Rio M, Sunkel C, Larcher F, Ortega MP.
    Br J Pharmacol; 1997 Apr 26; 120(7):1360-6. PubMed ID: 9105713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.